These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7942758)

  • 41. Treatment of Helicobacter pylori infection: a review.
    Blecker U; Gold BD
    Pediatr Infect Dis J; 1997 Apr; 16(4):391-9. PubMed ID: 9109142
    [No Abstract]   [Full Text] [Related]  

  • 42. [Helicobacter pylori eradication. Triple or quadruple therapy?, Long or short treatment?].
    Calvet X; Gené E
    Gastroenterol Hepatol; 2003 May; 26(5):325-9. PubMed ID: 12732108
    [No Abstract]   [Full Text] [Related]  

  • 43. Identification and eradication of Helicobacter pylori in an isolated patient population.
    Myers D
    Mil Med; 1997 Jul; 162(7):507-9. PubMed ID: 9232984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Helicobacter pylori eradication--understandable caution but no excuse for inertia.
    de Boer WA
    Aliment Pharmacol Ther; 1995 Feb; 9(1):85-6. PubMed ID: 7766750
    [No Abstract]   [Full Text] [Related]  

  • 45. Reflections on gastric ulcer disease.
    Tytgat GN
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):333-4. PubMed ID: 8781900
    [No Abstract]   [Full Text] [Related]  

  • 46. Antibacterial treatment of gastric ulcers.
    Harris A; Misiewicz JJ
    N Engl J Med; 1995 Jul; 333(3):191. PubMed ID: 7791827
    [No Abstract]   [Full Text] [Related]  

  • 47. [Progress in the pharmacotherapy of peptic ulcer].
    Stasiewicz J; Moniuszko-Jakoniuk J
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1721-5. PubMed ID: 6151657
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pathophysiologic bases of the pharmacotherapy of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Vasil'eva ZI
    Klin Med (Mosk); 1988 Nov; 66(11):19-27. PubMed ID: 2907071
    [No Abstract]   [Full Text] [Related]  

  • 49. 'Difficult' duodenal ulcer patients: clinical and therapeutic problems.
    Bianchi Porro G; Parente F
    Dig Dis; 1991; 9(4):219-28. PubMed ID: 1680585
    [No Abstract]   [Full Text] [Related]  

  • 50. [Anti-secretory agents modify the gastric localization of Helicobacter pylori].
    Zaterka S
    Arq Gastroenterol; 2001; 38(1):1-2. PubMed ID: 11582958
    [No Abstract]   [Full Text] [Related]  

  • 51. [Maintenance treatment after success of H. pylori eradication].
    Aoyama N; Shirasaka D; Miki I
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():523-30. PubMed ID: 11979840
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapy of reflux esophagitis].
    Berges W; Wienbeck M
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():15-7. PubMed ID: 7910994
    [No Abstract]   [Full Text] [Related]  

  • 53. Helicobacter pylori infection.
    Vakil N; Malfertheiner P; Chey WD
    N Engl J Med; 2010 Aug; 363(6):595; author reply 596. PubMed ID: 20818897
    [No Abstract]   [Full Text] [Related]  

  • 54. [Colloidal bismuth subcitrate: several pharmacokinetic considerations and of clinical application].
    Alcalde M; Sánchez P; Lancho A; Rodríguez SJ; Pajares García JM
    Rev Esp Enferm Dig; 1994 Nov; 86(5):823-30. PubMed ID: 7848694
    [No Abstract]   [Full Text] [Related]  

  • 55. Helicobacter pylori positive resistant duodenal ulcers.
    Moran A; Panos MZ; Asquith P
    Gut; 1993 Nov; 34(11):1647; author reply 1647-8. PubMed ID: 8244160
    [No Abstract]   [Full Text] [Related]  

  • 56. [Drug information. New bismuth preparation against presumed cause of gastric ulcer].
    Dahlerup J
    Sygeplejersken; 1989 Nov; 89(46):14-5. PubMed ID: 2617427
    [No Abstract]   [Full Text] [Related]  

  • 57. Laparoscopic vagotomy: an operation for the 1990s?
    Penston J
    Ann R Coll Surg Engl; 1994 May; 76(3):211-2. PubMed ID: 7912490
    [No Abstract]   [Full Text] [Related]  

  • 58. Gastroprotective effect of MX1 (a novel salt of the active metabolite of roxatidine with a complex of bismuth and citric acid) against stress ulcers in rats.
    Marazova K; Klouchek E; Popov A; Ivanov CH; Krushkov I
    J Pharm Pharmacol; 1997 Aug; 49(8):791-5. PubMed ID: 9379358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Helicobacter pylori infection in dialyzed patients: bismuth therapy and pharmacokinetics.
    Treiber G; Gadziwa U; Klotz U
    Nephron; 1992; 61(2):227. PubMed ID: 1630551
    [No Abstract]   [Full Text] [Related]  

  • 60. Bismuth salts in the treatment of Helicobacter pylori infection in children.
    Gökçe S
    Dig Dis Sci; 2010 Feb; 55(2):535-6. PubMed ID: 19960251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.